Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Snake-venom

Snake venoms are a mixture of hydrolases which produce complex pathogenesis such as bleeding, dermo/ myonecrosis, inflammation and coagulation disorders. The toxicity of venoms cannot be attributed to only one component. It is well known that venom components present antagonist activities, while some of them work synergistically. Binding to their intra- and extra-cellular or molecular targets, leads these components to generate severe disturbances which might concern several systems through complex mechanisms. Some of these mechanisms are still not yet elucidated. Thus, some of these components can act at different steps of blood coagulation by activating or inhibiting several molecular or cellular targets thereby inducing blood disorders. Despite their effects, it is well established that some of components from snake venoms present beneficial effects when acting alone as purified entity. Appropriate treatments of snakebite victims need a complete understanding of the pharmacological roles of the different venom components. Pathophysiological and Pharmacological Effects of Snake Venom Components: Molecular Targets: Laraba-Djebari Fatima and Chérifi Fatah. OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 700+ peer-reviewed journals and has organized over 3000+ International Scientific Conferences all over the world. OMICS International is has wide classification of journals and Entomology, Ornithology and Herpetology: Current Research is one of the important of them. Entomology, Ornithology and Herpetology: Current Research covers each and every aspect of gene studies from the very basic to the new advance.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2024

Top